276 related articles for article (PubMed ID: 30776365)
41. Direct analysis of bacterial viability in endotracheal tube biofilm from a pig model of methicillin-resistant Staphylococcus aureus pneumonia following antimicrobial therapy.
Fernández-Barat L; Li Bassi G; Ferrer M; Bosch A; Calvo M; Vila J; Gabarrús A; Martínez-Olondris P; Rigol M; Esperatti M; Luque N; Torres A
FEMS Immunol Med Microbiol; 2012 Jul; 65(2):309-17. PubMed ID: 22444646
[TBL] [Abstract][Full Text] [Related]
42. Vancomycin or linezolid empiric MRSA coverage with potential ventilator-associated pneumonia has no benefit or effect on outcomes: antibiotic stewardship implications.
Cunha BA; Jaber N; Blum S
Int J Antimicrob Agents; 2018 Nov; 52(5):733-734. PubMed ID: 29909171
[No Abstract] [Full Text] [Related]
43. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
Maclayton DO; Hall RG
Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
[TBL] [Abstract][Full Text] [Related]
44. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
45. Linezolid and vancomycin in treatment of lower-extremity complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus in patients with and without vascular disease.
Duane TM; Weigelt JA; Puzniak LA; Huang DB
Surg Infect (Larchmt); 2012 Jun; 13(3):147-53. PubMed ID: 22568921
[TBL] [Abstract][Full Text] [Related]
46. The impact of linezolid versus vancomycin on surgical interventions for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.
Duane TM; Capitano B; Puzniak LA; Biswas P; Joshi M
Surg Infect (Larchmt); 2013 Aug; 14(4):401-7. PubMed ID: 23859675
[TBL] [Abstract][Full Text] [Related]
47. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis.
Sipahi OR; Bardak-Ozcem S; Turhan T; Arda B; Ruksen M; Pullukcu H; Aydemir S; Dalbasti T; Yurtseven T; Sipahi H; Zileli M; Ulusoy S
Surg Infect (Larchmt); 2013 Aug; 14(4):357-62. PubMed ID: 23672240
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of Telavancin in Comparison to Linezolid in a Porcine Model of Severe Methicillin-Resistant Staphylococcus aureus Pneumonia.
Battaglini D; Motos A; Li Bassi G; Yang H; Pagliara F; Yang M; Aguilera Xiol E; Meli A; Bobi J; Frigola G; Senussi T; Idone F; Travierso C; Chiurazzi C; Fernandez-Barat L; Rigol M; Ramirez J; Pelosi P; Chiumello D; Antonelli M; Nicolau DP; Bringue J; Artigas A; Guerrero L; Soy D; Torres A
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046500
[TBL] [Abstract][Full Text] [Related]
49. Comparative Effectiveness of Vancomycin Versus Linezolid for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis.
Fusco NM; Meaney CJ; Frederick CA; Prescott WA
Ann Pharmacother; 2020 Mar; 54(3):197-204. PubMed ID: 31658825
[No Abstract] [Full Text] [Related]
50. Effect of linezolid compared with glycopeptides in methicillin-resistant Staphylococcus aureus severe pneumonia in piglets.
Luna CM; Bruno DA; García-Morato J; Mann KC; Risso Patrón J; Sagardía J; Absi R; García Bottino M; Marchetti D; Famiglietti A; Baleztena M; Biancolini C
Chest; 2009 Jun; 135(6):1564-1571. PubMed ID: 19141525
[TBL] [Abstract][Full Text] [Related]
51. Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP).
Shorr AF; Puzniak LA; Biswas P; Niederman MS
PLoS One; 2015; 10(7):e0131932. PubMed ID: 26196695
[TBL] [Abstract][Full Text] [Related]
52. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH
Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132
[TBL] [Abstract][Full Text] [Related]
53. A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients.
McCollum M; Sorensen SV; Liu LZ
Clin Ther; 2007 Mar; 29(3):469-77. PubMed ID: 17577468
[TBL] [Abstract][Full Text] [Related]
54. [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
Taşbakan MS; Korkmaz Ekren P; Pullukçu H; Başarık B; Susur A; Aydemir S; Başoğlu OK; Bacakoğlu F
Mikrobiyol Bul; 2010 Jul; 44(3):357-66. PubMed ID: 21063985
[TBL] [Abstract][Full Text] [Related]
55. Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case-control study.
Eliakim-Raz N; Hellerman M; Yahav D; Cohen J; Margalit I; Fisher S; Zusman O; Shaked H; Bishara J
J Antimicrob Chemother; 2017 Mar; 72(3):882-887. PubMed ID: 27999052
[TBL] [Abstract][Full Text] [Related]
56. New therapy options for MRSA with respiratory infection/pneumonia.
Ramirez P; Fernández-Barat L; Torres A
Curr Opin Infect Dis; 2012 Apr; 25(2):159-65. PubMed ID: 22248980
[TBL] [Abstract][Full Text] [Related]
57. What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia?
Peyrani P; Ramirez J
Curr Opin Infect Dis; 2015 Apr; 28(2):164-70. PubMed ID: 25692268
[TBL] [Abstract][Full Text] [Related]
58. Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population.
Gonzalez RP; Rostas J; Simmons JD; Allen J; Frotan MA; Brevard SB
Am J Surg; 2013 Mar; 205(3):255-8; discussion 258. PubMed ID: 23375761
[TBL] [Abstract][Full Text] [Related]
59. Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages.
Jacqueline C; Broquet A; Roquilly A; Davieau M; Caillon J; Altare F; Potel G; Asehnoune K
J Infect Dis; 2014 Sep; 210(5):814-23. PubMed ID: 24620024
[TBL] [Abstract][Full Text] [Related]
60. Economic evaluation among Chinese patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus and treated with linezolid or vancomycin: a secondary, post-hoc analysis based on a Phase 4 clinical trial study.
Wan Y; Li Q; Chen Y; Haider S; Liu S; Gao X
J Med Econ; 2016; 19(1):53-62. PubMed ID: 26490296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
